Comparative analysis of the efficacy and safety of antibody‑drug conjugates, radionuclide‑drug conjugates and their combination targeting claudin 18.2 in gastric cancer treatment.

Although the sample size (n=5/group) in the current study was limited, resulting in a low statistical power, and this difference did not reach statistical significance after correction for multiple comparisons, the magnitude of the observed trend and effect size still suggests that the sequence of administration may be a potential factor influencing antitumor efficacy.

also in 111,027 other papers